Kodiak Sciences Announces Completion Of 300-Patient Enrollment In First Pivotal Cohort Of Phase 3 PEAK Trial For KSI-101; Says Topline Data On Track For December 2026

Loading news article.

Kodiak Sciences Announces Completion Of 300-Patient Enrollment In First Pivotal Cohort Of Phase 3 PEAK Trial For KSI-101; Says Topline Data On Track For December 2026 | WAPE

Kodiak Sciences Announces Completion Of 300-Patient Enrollment In First Pivotal Cohort Of Phase 3 PEAK Trial For KSI-101; Says Topline Data On Track For December 2026

Article summary

Related companies

Comments —